title: Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
abstract: BACKGROUND
  CSF-2 and CSF-3 confer proangiogenic and immunomodulatory properties to mesenchymal stromal cells (MSCs).
  
  
  RESULTS
  Transcriptional regulation of CSF-2 and CSF-3 in concanavalin A-activated MSCs requires MT1-MMP signaling and is inhibited by EGCG.
  
  
  CONCLUSIONS
  The chemopreventive properties of diet-derived EGCG alter MT1-MMP-mediated intracellular signaling.
  
  
  CONCLUSIONS
  Pharmacological targeting of MSCs proangiogenic functions may prevent their contribution to tumor development. Epigallocatechin gallate (EGCG), a major form of tea catechins, possesses immunomodulatory and antiangiogenic effects, both of which contribute to its chemopreventive properties. In this study, we evaluated the impact of EGCG treatment on the expression of colony-stimulating factors (CSF) secreted from human bone marrow-derived mesenchymal stromal cells (MSCs), all of which also contribute to the immunomodulatory and angiogenic properties of these cells. MSCs were activated with concanavalin A (ConA), a Toll-like receptor (TLR)-2 and TLR-6 agonist as well as a membrane type 1 matrix metalloproteinase (MT1-MMP) inducer, which increased granulocyte macrophage-CSF (GM-CSF, CSF-2), granulocyte CSF (G-CSF, CSF-3), and MT1-MMP gene expression. EGCG antagonized the ConA-induced CSF-2 and CSF-3 gene expression, and this process required an MT1-MMP-mediated sequential activation of the Src and JAK/STAT pathways. Gene silencing of MT1-MMP expression further demonstrated its requirement in the phosphorylation of Src and STAT3, whereas overexpression of a nonphosphorylatable MT1-MMP mutant (Y573F) abrogated CSF-2 and CSF-3 transcriptional increases. Given that MSCs are recruited within vascularizing tumors and are believed to contribute to tumor angiogenesis, possibly through secretion of CSF-2 and CSF-3, our study suggests that diet-derived polyphenols such as EGCG may exert chemopreventive action through pharmacological targeting of the MT1-MMP intracellular signaling.
authors.affiliation: Laboratoire d'Oncologie Moléculaire, Centre de Recherche BIOMED, Département de Chimie, Université du Québec à Montreal, Montreal, Quebec, Canada H3C 3P8.
authors.forename: Alain
authors.initials: A
authors.lastname: Zgheib
authors.forename: Sylvie
authors.initials: S
authors.lastname: Lamy
authors.forename: Borhane
authors.initials: B
authors.lastname: Annabi
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D020868:Gene Silencing / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000235:genetics* / Q000378:metabolism; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D053612:Janus Kinases / Q000378:metabolism; D016173:Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000378:metabolism; D053511:Matrix Metalloproteinase 14 / Q000235:genetics / Q000378:metabolism*; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000378:metabolism*; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D050796:STAT3 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction; D051195:Toll-Like Receptor 2 / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D051216:Toll-Like Receptor 6 / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic; D019061:src-Family Kinases / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C495342:TLR2 protein, human; C495368:TLR6 protein, human; D051195:Toll-Like Receptor 2; D051216:Toll-Like Receptor 6; D003208:Concanavalin A; D016179:Granulocyte Colony-Stimulating Factor; D016173:Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002392:Catechin; C045651:epigallocatechin gallate; D053612:Janus Kinases; D019061:src-Family Kinases; C507086:MMP14 protein, human; D053511:Matrix Metalloproteinase 14
keywords: Angiogenesis; Cancer Chemoprevention; Cytokine Induction; Green Tea EGCG; Matrix Metalloproteinase (MMP); Mesenchymal Stem Cells
references.citation: J Cell Biochem. 2004 Apr 15;91(6):1146-58
references.pmid: 15048870
references.citation: Clin Transl Oncol. 2011 Sep;13(9):611-6
references.pmid: 21865132
references.citation: Leuk Res. 2012 May;36(5):537-43
references.pmid: 22386730
references.citation: Biochim Biophys Acta. 2010 Jan;1803(1):133-41
references.pmid: 19406172
references.citation: Curr Pharm Des. 2007;13(17):1787-802
references.pmid: 17584108
references.citation: Angiogenesis. 2012 Sep;15(3):443-55
references.pmid: 22527199
references.citation: FEBS Lett. 2011 Mar 9;585(5):814-20
references.pmid: 21320497
references.citation: Carcinogenesis. 2008 Aug;29(8):1655-64
references.pmid: 18621744
references.citation: J Cell Sci. 2010 Dec 1;123(Pt 23):4182-93
references.pmid: 21062896
references.citation: Glycobiology. 2012 Sep;22(9):1245-55
references.pmid: 22692046
references.citation: J Cell Physiol. 1993 Apr;155(1):89-95
references.pmid: 7682223
references.citation: Exp Hematol. 2003 Jul;31(7):640-9
references.pmid: 12842709
references.citation: Exp Ther Med. 2013 Feb;5(2):438-442
references.pmid: 23403478
references.citation: Int Immunopharmacol. 2011 Oct;11(10):1407-14
references.pmid: 21600311
references.citation: Blood. 2001 Jun 1;97(11):3433-40
references.pmid: 11369634
references.citation: Eur J Immunol. 1985 May;15(5):479-86
references.pmid: 3873340
references.citation: J Neurooncol. 2007 Jul;83(3):241-7
references.pmid: 17570034
references.citation: Cancer Metastasis Rev. 2010 Jun;29(2):249-61
references.pmid: 20411303
references.citation: J Clin Invest. 1991 Mar;87(3):986-95
references.pmid: 1705569
references.citation: J Mol Cell Cardiol. 2011 Feb;50(2):280-9
references.pmid: 20727900
references.citation: Cells. 2012 Oct 17;1(4):832-50
references.pmid: 24710532
references.citation: J Biol Chem. 2007 Mar 16;282(11):8142-9
references.pmid: 17229722
references.citation: Cancer Res. 2012 May 1;72(9):2339-49
references.pmid: 22406620
references.citation: Target Oncol. 2012 Mar;7(1):29-54
references.pmid: 22399234
references.citation: Biochem Biophys Res Commun. 2012 Oct 5;426(4):480-5
references.pmid: 22960171
references.citation: Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):419-27
references.pmid: 19926330
references.citation: Nature. 1989 Feb 2;337(6206):471-3
references.pmid: 2464767
references.citation: J Nutr Sci Vitaminol (Tokyo). 2001 Dec;47(6):402-8
references.pmid: 11922115
references.citation: Stem Cells. 2006 Nov;24(11):2557-65
references.pmid: 16931773
references.citation: J Biol Chem. 2012 Mar 30;287(14):11533-45
references.pmid: 22315223
references.citation: Stem Cells. 2009 Mar;27(3):489-97
references.pmid: 19074414
references.citation: J Biol Chem. 2013 Apr 12;288(15):10195-204
references.pmid: 23413031
references.citation: Cancer Lett. 2009 Jul 8;279(2):171-6
references.pmid: 19264392
references.citation: J Biol Chem. 2004 May 21;279(21):21888-96
references.pmid: 15016831
references.citation: J Biol Chem. 2007 May 25;282(21):15690-9
references.pmid: 17389600
references.citation: J Neuroinflammation. 2009 Mar 09;6:8
references.pmid: 19272160
references.citation: Biofactors. 2010 Jul-Aug;36(4):248-54
references.pmid: 20818710
references.citation: Biochim Biophys Acta. 2002 Jan 30;1542(1-3):209-20
references.pmid: 11853893
references.citation: Exp Cell Res. 2012 Nov 15;318(19):2498-506
references.pmid: 22971618
references.citation: ScientificWorldJournal. 2011 Apr 19;11:981-91
references.pmid: 21516292
references.citation: J Biol Chem. 2009 Jul 24;284(30):19791-9
references.pmid: 19458085
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):351-4
references.pmid: 9568793
references.citation: Oncogene. 2013 Sep 12;32(37):4343-54
references.pmid: 23085755
references.citation: Oncogene. 2004 Jan 15;23(2):317-29
references.pmid: 14724562
references.citation: World J Gastroenterol. 2012 Sep 21;18(35):4925-33
references.pmid: 23002366
references.citation: Cardiovasc Res. 2006 Apr 1;70(1):61-9
references.pmid: 16448633